Publications

Selected publications from André Rogatko and Mourad Tighiouart are posted on this page and categoried by their topics.

Cancer Phase I Clinical Trials

• Babb,J. and Rogatko,A. 'Patient specific dosing in a cancer phase I clinical trial', Statistics in Medicine, 20, 2079-2090 (2001)
• Cheng,J., Babb,J., Langer,C., Aamdal,S., Robert,F., Engelhardt,L., Fernberg,O., Schiller,J., Forsberg,G., Alpaugh,K., Weiner,L. and Rogatko,A. 'Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936', Journal of Clinical Oncology, 22, 602-609 (2004)
• Tighiouart, M., Rogatko,A., and Babb, J. 'Flexible Bayesian Methods for Cancer Phase I Clinical Trials: Dose Escalation With Overdose Control', Statistics in Medicine, 24, 2183-2196 (2005)
• Rogatko,A., Babb,J., Tighiouart, M., Khuri,F., and Hudes, G. 'New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I', Clinical Cancer Research, 11(15): 5342-5346 (2005)
• Rogatko, A, Schoeneck, D, Jonas, W, Tighiouart, M, Khouri, F, Porter, Alan. 'Translation of Innovative Designs into Cancer Phase I Trials'. Journal of Clinical Oncology, 25 (31), 4982-4986 (2007)
• Xu. Z, Tighiouart, M., and Rogatko, A. 'EWOC 2.0: Interactive Software for Dose Escalation in Cancer Phase I Clinical Trials'. Drug Information Journal, 41, 221-228 (2007)
• Rogatko, A, Ghosh, P, Vidakovic, B, and Tighiouart, M.'Patient-Specific Dose Adjustment in the Cancer Clinical Trial Setting'. Pharmaceutical Medicine, 22 (6): 345-350 (2008)
• ---Paper Under Preparation---

HWDIAG

• Rogatko,A., Slifker,M. and Babb,J. 'Hardy-Weinberg Equilibrium Diagnostics', Theoretical Population Biology, 62, 251-257 (2002)